{"DataElement":{"publicId":"7366195","version":"1","preferredName":"Pioglitazone Receive Yes No Does Not Know Indicator","preferredDefinition":"The yes/no/does not know indicator as to whether the patient received pioglitazone, an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity.","longName":"7366151v1.0:3270332v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"7366151","version":"1","preferredName":"Pioglitazone Receive","preferredDefinition":"An orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation._To take, accept, or get something offered.","longName":"7366149v1.0:2184327v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"7366149","version":"1","preferredName":"Pioglitazone","preferredDefinition":"An orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation.","longName":"C71633","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pioglitazone","conceptCode":"C71633","definition":"An orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB1E106A-DD5E-4C87-E053-4EBD850A5D70","latestVersionIndicator":"Yes","beginDate":"2020-07-23","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-07-23","modifiedBy":"ONEDATA","dateModified":"2020-07-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2184327","version":"1","preferredName":"Received","preferredDefinition":"Received; taken, gotten, or acquired.","longName":"Received","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Receive","conceptCode":"C25639","definition":"To take, accept, or get something offered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1F66-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB1E106A-DD6C-4C87-E053-4EBD850A5D70","latestVersionIndicator":"Yes","beginDate":"2020-07-23","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-07-23","modifiedBy":"MORENOC","dateModified":"2020-11-18","changeDescription":"11/18/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3270332","version":"1","preferredName":"Yes No Does Not Know Indicator","preferredDefinition":"The affirmative response to a question or activity._The non-affirmative response to a question._The answer is not known by the person answering._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"3270332v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Don't know","valueDescription":"Don't Know/Refused","ValueMeaning":{"publicId":"2654058","version":"1","preferredName":"Don't Know/Refused","longName":"2654058","preferredDefinition":"The answer is not known by the person answering.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Does Not Know","conceptCode":"C67142","definition":"The answer is not known by the person answering.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32BD33B1-0E11-3D3A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-12","endDate":null,"createdBy":"UMLLOADER_TOBACCO","dateCreated":"2007-06-12","modifiedBy":"TSESU","dateModified":"2023-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AC6190CA-F659-268C-E040-BB89AD432A45","beginDate":"2011-09-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-07","modifiedBy":"ONEDATA","dateModified":"2011-09-07","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"2559515","version":"1","preferredName":"No","longName":"2559515","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B588-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AC6190CA-F663-268C-E040-BB89AD432A45","beginDate":"2011-09-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-07","modifiedBy":"ONEDATA","dateModified":"2011-09-07","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"2560453","version":"1","preferredName":"Yes","longName":"2560453","preferredDefinition":"The affirmative response to a question or activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AC6190CA-F66D-268C-E040-BB89AD432A45","beginDate":"2011-09-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-07","modifiedBy":"ONEDATA","dateModified":"2011-09-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3270331","version":"1","preferredName":"Yes No Does Not Know Indicator","preferredDefinition":"The affirmative response to a question or activity.:The non-affirmative response to a question.:The answer is not known by the person answering.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C49488:C49487:C67142:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Does Not Know","conceptCode":"C67142","definition":"The answer is not known by the person answering.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC6190CA-F632-268C-E040-BB89AD432A45","latestVersionIndicator":"Yes","beginDate":"2011-09-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-07","modifiedBy":"ONEDATA","dateModified":"2011-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC6190CA-F643-268C-E040-BB89AD432A45","latestVersionIndicator":"Yes","beginDate":"2011-09-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-07","modifiedBy":"PWEST","dateModified":"2015-11-02","changeDescription":"Released per approval by S.Shakour. mc 9/21/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pioglitazone","type":"Preferred Question Text","description":"Pioglitazone","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB1D8697-C16A-70C9-E053-4EBD850A211E","latestVersionIndicator":"Yes","beginDate":"2020-07-23","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-07-23","modifiedBy":"MORENOC","dateModified":"2020-11-18","changeDescription":"11/18/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}